Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam versus dexmedetomidine for attenuation of intubation stress response in controlled hypertensive adults undergoing elective surgery
PACTR201909641727181Phase 3Recruiting
- Sponsor
- eman sayed
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in hypertension (HTN) comparing midazolam group with dexmedetomidine group (2 arms). Primary endpoints: Mean arterial blood pressure and Heart rate. Started Jan 2018; status: recruiting.
02
Drugs
midazolamdexmedetomidine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on PACTR201909641727181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201909641727181.